Terms: = Prostate cancer AND PR, PGR, progesterone receptor AND Clinical Outcome
13 results:
1. Early biochemical and radiographic response after one cycle of [
Cytawa W; Hendel R; Tomasik B; Weinzierl FX; Bley T; Jassem J; Schirbel A; Buck AK; Bundschuh RA; Hartrampf PE; Werner RA; Lapa C
Eur J Nucl Med Mol Imaging; 2023 Oct; 50(12):3765-3776. PubMed ID: 37474735
[TBL] [Abstract] [Full Text] [Related]
2. Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis.
Rajan A; Nadhan R; Latha NR; Krishnan N; Warrier AV; Srinivas P
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188482. PubMed ID: 33260050
[TBL] [Abstract] [Full Text] [Related]
3. Therapeutic efficacy, prognostic variables and clinical outcome of
Suman S; Parghane RV; Joshi A; Prabhash K; Bakshi G; Talole S; Banerjee S; Basu S
Br J Radiol; 2019 Dec; 92(1104):20190380. PubMed ID: 31600089
[TBL] [Abstract] [Full Text] [Related]
4. A comparison of treatment outcome between fiducial-based and bone-based image guided radiotherapy in prostate cancer patients.
Napieralska A; Majewski W; Kulik R; Głowacki G; Miszczyk L
Radiat Oncol; 2018 Nov; 13(1):235. PubMed ID: 30482212
[TBL] [Abstract] [Full Text] [Related]
5. progesterone receptor modulates ERα action in breast cancer.
Mohammed H; Russell IA; Stark R; Rueda OM; Hickey TE; Tarulli GA; Serandour AA; Birrell SN; Bruna A; Saadi A; Menon S; Hadfield J; Pugh M; Raj GV; Brown GD; D'Santos C; Robinson JL; Silva G; Launchbury R; Perou CM; Stingl J; Caldas C; Tilley WD; Carroll JS
Nature; 2015 Jul; 523(7560):313-7. PubMed ID: 26153859
[TBL] [Abstract] [Full Text] [Related]
6. PTEN Loss Is Associated with Worse outcome in HER2-Amplified Breast cancer Patients but Is Not Associated with Trastuzumab Resistance.
Stern HM; Gardner H; Burzykowski T; Elatre W; O'Brien C; Lackner MR; Pestano GA; Santiago A; Villalobos I; Eiermann W; Pienkowski T; Martin M; Robert N; Crown J; Nuciforo P; Bee V; Mackey J; Slamon DJ; Press MF
Clin Cancer Res; 2015 May; 21(9):2065-74. PubMed ID: 25649019
[TBL] [Abstract] [Full Text] [Related]
7. Aurora-A expression, hormone receptor status and clinical outcome in hormone related cancers.
Das K; Lorena PD; Ng LK; Shen L; Lim D; Siow WY; Narasimhan K; Teh M; Choolani M; Putti TC; Salto-Tellez M
Pathology; 2010; 42(6):540-6. PubMed ID: 20854072
[TBL] [Abstract] [Full Text] [Related]
8. Identification of 5 novel genes methylated in breast and other epithelial cancers.
Hill VK; Hesson LB; Dansranjavin T; Dallol A; Bieche I; Vacher S; Tommasi S; Dobbins T; Gentle D; Euhus D; Lewis C; Dammann R; Ward RL; Minna J; Maher ER; Pfeifer GP; Latif F
Mol Cancer; 2010 Mar; 9():51. PubMed ID: 20205715
[TBL] [Abstract] [Full Text] [Related]
9. Nuclear detection of Y-box protein-1 (YB-1) closely associates with progesterone receptor negativity and is a strong adverse survival factor in human breast cancer.
Dahl E; En-Nia A; Wiesmann F; Krings R; Djudjaj S; Breuer E; Fuchs T; Wild PJ; Hartmann A; Dunn SE; Mertens PR
BMC Cancer; 2009 Nov; 9():410. PubMed ID: 19930682
[TBL] [Abstract] [Full Text] [Related]
10. progesterone receptor is a significant factor associated with clinical outcomes and effect of adjuvant tamoxifen therapy in breast cancer patients.
Liu S; Chia SK; Mehl E; Leung S; Rajput A; Cheang MC; Nielsen TO
Breast Cancer Res Treat; 2010 Jan; 119(1):53-61. PubMed ID: 19205877
[TBL] [Abstract] [Full Text] [Related]
11. prostate cancer with small-cell morphology: an immunophenotypic subdivision.
Petraki C; Vaslamatzis M; Petraki K; Revelos K; Alevizopoulos N; Papanastasiou P; Gregorakis A
Scand J Urol Nephrol; 2005; 39(6):455-63. PubMed ID: 16303720
[TBL] [Abstract] [Full Text] [Related]
12. Apolipoprotein E polymorphism and breast carcinoma: correlation with cell proliferation indices and clinical outcome.
Zunarelli E; Nicoll JA; Migaldi M; Trentini GP
Breast Cancer Res Treat; 2000 Oct; 63(3):193-8. PubMed ID: 11110053
[TBL] [Abstract] [Full Text] [Related]
13. Endocrine therapy of breast and prostate cancer.
Manni A
Endocrinol Metab Clin North Am; 1989 Jun; 18(2):569-92. PubMed ID: 2663486
[TBL] [Abstract] [Full Text] [Related]
